Clinical Instructor
[email protected]
Available to mentor
Avinash Maganty
Clinical Instructor
-
MDWeill Cornell Medicine, New York
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Center MemberPrecision Health Initiative
-
Faraj KS, Kaufman SR, Oerline M, Herrel LA, Maganty A, Caram MEV, Shahinian VB, Hollenbeck BK. Cancer, 2024 Jun 15; 130 (12): 2160 - 2168.Journal ArticleThe 340B Program and oral specialty drugs for advanced prostate cancer.
DOI:10.1002/cncr.35262 PMID: 38395607 -
Sekar R, Herrel L, Stensland K, Maganty A. Journal of Urology, 2024 May; 211 (5S): e576Journal ArticleMP34-15 THE ASSOCIATION BETWEEN INDIVIDUAL AND POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH AND CLINICAL TRIALS AWARENESS: A HINTS-SEER ANALYSIS
DOI:10.1097/01.ju.0001008876.78012.90.15 -
Irani S, Maganty A, Stensland K, Herrel L, Sekar R. Journal of Urology, 2024 May; 211 (5S): e577Journal ArticleMP34-16 DISPARITIES IN PRECISION MEDICINE AND GENETIC TESTING IN PATIENTS WITH UROLOGIC CANCERS
DOI:10.1097/01.ju.0001008876.78012.90.16 -
Faraj K, Kaufman S, Herrel L, Maganty A, Oerline M, Caram M, Shahinian V, Hollenbeck B. Journal of Urology, 2024 May; 211 (5S): e943Journal ArticleMP57-14 THE IMMEDIATE EFFECTS OF PRIVATE EQUITY ACQUISITION OF UROLOGY PRACTICES ON THE MANAGEMENT OF NEWLY DIAGNOSED PROSTATE CANCER
DOI:10.1097/01.ju.0001009420.83948.eb.14 -
Faraj K, Oerline M, Kaufman S, Maganty A, Caram M, Shahinian V, Hollenbeck B. Journal of Urology, 2024 May; 211 (5S): e66Journal ArticlePD01-08 QUALITY OF TREATMENT WITH TARGETED THERAPIES FOR ADVANCED PROSTATE CANCER BY SPECIALIST: DO PATIENTS WHO ARE MANAGED BY UROLOGISTS FARE DIFFERENTLY?
DOI:10.1097/01.ju.0001009540.33579.43.08 -
Dhir A, Maganty A, Stensland KD, Herrel LA, Sekar R. Journal of Urology, 2024 May; 211 (5S): e175Journal ArticlePD08-07 DETERMINANTS OF FINANCIAL TOXICITY IN PATIENTS WITH UROLOGIC CANCER
DOI:10.1097/01.ju.0001008576.33217.96.07 -
Faraj K, Kaufman S, Herrel L, Maganty A, Oerline M, Caram M, Shahinian V, Hollenbeck B. Journal of Urology, 2024 May; 211 (5S): e1210Journal ArticlePD57-06 UROLOGIST PRACTICE DIVESTMENT FROM RADIATION VAULT OWNERSHIP AND TREATMENT PATTERNS FOR PROSTATE CANCER
DOI:10.1097/01.ju.0001008808.16085.aa.06 -
Faraj KS, Kaufman SR, Herrel LA, Maganty A, Oerline MK, Caram MEV, Shahinian VB, Hollenbeck BK. Cancer, 2024 May 1; 130 (9): 1609 - 1617.Journal ArticleUrologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
DOI:10.1002/cncr.35168 PMID: 38146764